Arcutis Biotherapeutics, Inc. (ARQT): Cash & Equivalents
$42.91M
As of 2025-12-31
$34.12M
As of 2026-06-30
-7.2%
3-year compound annual growth
-8.0%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $42.91M | -39.9% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $71.33M | -19.3% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $88.39M | +64.8% | 2025-02-25, Balance as of period end |
| 2022-12-31 | $53.64M | -44.4% | 2024-02-27, Balance as of period end |
| 2021-12-31 | $96.45M | +48.2% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $65.08M | +2.8% | 2022-02-22, Balance as of period end |
| 2019-12-31 | $63.34M | n/a | 2021-02-16, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $42.91M | -39.9% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $488.25M | +45.6% |
| MannKind Corp (MNKD) | 2025-12-31 | $74.88M | +61.6% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $68.00M | +4.7% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $550.94M | +80.7% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $144.84M | +256.3% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $679.57M | +51.1% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $53.83M | -38.1% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $215.46M | +143.3% |
Compare ARQT, SVA, MNKD, ARDX side by side · Screen every company in Pharmaceutical Preparations ↗